Integer Holdings Co. (NYSE:ITGR) Shares Sold by Gabelli Funds LLC

Gabelli Funds LLC reduced its position in Integer Holdings Co. (NYSE:ITGR) by 15.7% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 95,171 shares of the medical equipment provider’s stock after selling 17,700 shares during the quarter. Gabelli Funds LLC’s holdings in Integer were worth $11,105,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. Blue Trust Inc. grew its position in Integer by 483.3% in the 4th quarter. Blue Trust Inc. now owns 455 shares of the medical equipment provider’s stock valued at $45,000 after acquiring an additional 377 shares in the last quarter. Principal Securities Inc. acquired a new position in Integer in the 4th quarter valued at about $67,000. Headlands Technologies LLC acquired a new position in Integer in the 1st quarter valued at about $106,000. Quadrant Capital Group LLC grew its position in Integer by 10.2% in the 4th quarter. Quadrant Capital Group LLC now owns 1,427 shares of the medical equipment provider’s stock valued at $141,000 after acquiring an additional 132 shares in the last quarter. Finally, Strs Ohio grew its position in shares of Integer by 54.5% during the fourth quarter. Strs Ohio now owns 1,700 shares of the medical equipment provider’s stock worth $168,000 after buying an additional 600 shares in the last quarter. 99.29% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at Integer

In other Integer news, EVP John A. Harris sold 312 shares of the business’s stock in a transaction that occurred on Tuesday, May 7th. The stock was sold at an average price of $113.00, for a total value of $35,256.00. Following the completion of the sale, the executive vice president now owns 1,157 shares in the company, valued at $130,741. The sale was disclosed in a document filed with the SEC, which is available through this link. In other news, VP Tommy P. Thomas sold 1,500 shares of the company’s stock in a transaction that occurred on Tuesday, April 30th. The stock was sold at an average price of $114.00, for a total transaction of $171,000.00. Following the completion of the sale, the vice president now owns 2,813 shares in the company, valued at $320,682. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP John A. Harris sold 312 shares of the company’s stock in a transaction that occurred on Tuesday, May 7th. The stock was sold at an average price of $113.00, for a total value of $35,256.00. Following the sale, the executive vice president now owns 1,157 shares of the company’s stock, valued at approximately $130,741. The disclosure for this sale can be found here. Over the last quarter, insiders sold 17,936 shares of company stock worth $2,130,937. 2.00% of the stock is owned by insiders.

Integer Stock Up 1.0 %

ITGR traded up $1.13 on Friday, reaching $116.81. The company’s stock had a trading volume of 460,076 shares, compared to its average volume of 392,735. The stock has a 50 day moving average of $119.03 and a two-hundred day moving average of $113.27. The company has a quick ratio of 2.01, a current ratio of 3.29 and a debt-to-equity ratio of 0.73. The company has a market capitalization of $3.91 billion, a price-to-earnings ratio of 40.42, a P/E/G ratio of 1.72 and a beta of 1.11. Integer Holdings Co. has a fifty-two week low of $69.40 and a fifty-two week high of $130.15.

Integer (NYSE:ITGR) last announced its quarterly earnings results on Thursday, July 25th. The medical equipment provider reported $1.30 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.24 by $0.06. Integer had a return on equity of 11.48% and a net margin of 6.31%. The firm had revenue of $436.20 million during the quarter, compared to the consensus estimate of $437.00 million. During the same period in the prior year, the company posted $1.14 earnings per share. The firm’s quarterly revenue was up 9.0% compared to the same quarter last year. As a group, analysts forecast that Integer Holdings Co. will post 5.3 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on the company. KeyCorp boosted their price objective on Integer from $123.00 to $139.00 and gave the stock an “overweight” rating in a research report on Tuesday, April 9th. Bank of America raised Integer from a “neutral” rating to a “buy” rating and boosted their price objective for the stock from $105.00 to $135.00 in a research report on Monday, April 15th. Citigroup boosted their price objective on Integer from $118.00 to $124.00 and gave the stock a “neutral” rating in a research report on Wednesday, May 22nd. Benchmark reissued a “buy” rating and set a $130.00 price objective on shares of Integer in a research report on Friday, May 10th. Finally, Truist Financial assumed coverage on Integer in a research report on Wednesday, May 15th. They set a “buy” rating and a $137.00 price objective for the company. Three analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $128.88.

Integer Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.